Hyperglycemia and loss of ovarian hormones mediate atheroma formation through endothelial layer disruption and increased permeability

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 292, Issue 2, 2007, Pages

  Benton, Jeana ^a,c   Powers, Andrew ^a   Eiselein, Larissa ^a   Fitch, Richard ^a   Wilson, Dennis ^b   Villablanca, Amparo C ^a   Rutledge, John C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Diabetes; Pathophysiology; Postmenopause; Vascular

Indexed keywords

HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROMA; CELL MEMBRANE PERMEABILITY; CHOLESTEROL DIET; CYTOPLASM; EVALUATION; FEMALE; HYPERGLYCEMIA; MOUSE; NONHUMAN; OVARIECTOMY; OVARY FUNCTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN INTERACTION; ULTRASTRUCTURE;

ANIMALS; ATHEROSCLEROSIS; BLOOD GLUCOSE; BODY WEIGHT; CAPILLARY PERMEABILITY; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; FEMALE; FLUORESCENT DYES; HYPERGLYCEMIA; LIPOPROTEINS, LDL; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; ORGAN SIZE; OVARIECTOMY; REGIONAL BLOOD FLOW; UTERUS;

EID: 33846817387     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00112.2006     Document Type: Article

References (47)

1. Andreassen TT, Seyer-Hansen K, Oxlund H. Biomechanical changes in connective tissues induced by experimental diabetes. Acta Endocrinol 98: 432-436, 1981.
2. Basta G, Schmidt AM, De Caterina R. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63: 582-592, 2004.
3. Bates DO, Harper SJ. Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 39: 225-237, 2002.
4. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48: 1-9, 1999.
5. Bjarnason NH, Haarbo J, Byrjalsen I, Alexandersen P, Kauffman RF, Christiansen C. Raloxifene and estrogen reduces progression of advanced atherosclerosis-a study in ovariectomized, cholesterol-fed rabbits. Atherosclerosis 154: 97-102, 2001.
6. Bruel A, Ortoft G, Oxlund H. Inhibition of cross-links in collagen is associated with reduced stiffness of the aorta in young rats. Atherosclerosis 140: 135-145, 1998.
7. Bucciarelli LG, Wendt T, Rong L, Lalla E, Hofmann MA, Goova MT, Taguchi A, Yan SF, Yan SD, Stern DM, Schmidt AM. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol Life Sci 59: 1117-1128, 2002.
8. Camejo G, Olsson U, Hurt-Camejo E, Baharamian N, Bondjers G. The extracellular matrix on atherogenesis and diabetes-associated vascular disease. Atheroscler Suppl 3: 3-9, 2002.
9. Cho MM, Ziats NP, Abdul-Karim FW, Pal D, Goldfarb J, Utian WH, Gorodeski GI. Effects of estrogen on tight junctional resistance in cultured human umbilical vein endothelial cells. J Soc Gynecol Investig 5: 260-270, 1998.
10. Cho MM, Ziats NP, Pal D, Utian WH, Gorodeski GI. Estrogen modulates paracellular permeability of human endothelial cells by eNOS- and iNOS-related mechanisms. Am J Physiol Cell Physiol 276: C337-C349, 1999.
11. Chung SS, Chung SK. Aldose reductase in diabetic microvascular complications. Curr Drug Targets 6: 475-486, 2005.
12. Collins AR, Meehan WP, Kintscher U, Jackson S, Wakino S, Noh G, Palinski W, Hsueh WA, Law RE. Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 21: 365-371, 2001.
13. Creager MA, Luscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 108: 1527-1532, 2003.
14. Delarue F, Daunes S, Elhage R, Garcia A, Bayard F, Faye J. Estrogens modulate bovine vascular endothelial cell permeability and HSP 25 expression concomitantly. Am J Physiol Heart Circ Physiol 275: H1011-H1015, 1998.
15. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J 10: 615-624, 1996.
16. Finking G, Gohar MH, Lenz C, Hanke H. Cardiovascular oestrogen effects in women. J Obstet Gynaecol 21: 340-349, 2001.
17. Gammal EB, Monture MC. Uptake of Evans blue-bound albumin in the aorta of oestrogen-treated rats. Br J Exp Pathol 60: 58-64, 1979.
18. Gardner G, Banka CL, Roberts KA, Mullick AE, Rutledge JC. Modified LDL-mediated increases in endothelial layer permeability are attenuated with 17β-estradiol. Arterioscler Thromb Vasc Biol 19: 854-861, 1999.
19. Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, Furberg CD, Kowalchuk GJ, Stuckey TD, Rogers WJ, Givens DH, Waters D. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med 343: 522-529, 2000.
20. Hodgin JB, Maeda N. Minireview: estrogen and mouse models of atherosclerosis. Endocrinology 143: 4495-4501, 2002.
21. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 280: 605-613, 1998.
22. Kunjathoor VV, Wilson DL, LeBoeuf RC. Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest 97: 1767-1773, 1996.
23. Litwak KN, Cefalu WT, Wagner JD. Chronic hyperglycemia increases arterial low-density lipoprotein metabolism and atherosclerosis in cynomolgus monkeys. Metabolism 47: 947-954, 1998.
24. Luscher TF, Creager MA, Beckman JA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II. Circulation 108: 1655-1661, 2003.
25. Misra A, Kumar S, Kishore Vikram N, Kumar A. The role of lipids in the development of diabetic microvascular complications: implications for therapy. Am J Cardiovasc Drugs 3: 325-338, 2003.
26. Monnier VM. Transition metals redox: reviving an old plot for diabetic vascular disease. J Clin Invest 107: 799-801, 2001.
27. Mullick AE, McDonald JM, Melkonian G, Talbot P, Pinkerton KE, Rutledge JC. Reactive carbonyls from tobacco smoke increase arterial endothelial layer injury. Am J Physiol Heart Circ Physiol 283: H591-H597, 2002.
28. Mullick AE, Walsh BA, Reiser KM, Rutledge JC. Chronic estradiol treatment attenuates stiffening, glycoxidation, and permeability in rat carotid arteries. Am J Physiol Heart Circ Physiol 281: H2204-H2210, 2001.
29. Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD. Post-menopausal hormone replacement therapy: scientific review. JAMA 288: 872-881, 2002.
30. Nordestgaard BG, Zilversmit DB. Comparison of arterial intimal clearances of LDL from diabetic and nondiabetic cholesterol-fed rabbits. Differences in intimal clearance explained by size differences. Arteriosclerosis 9: 176-183, 1989.
31. Paigen B, Morrow A, Brandon C, Mitchell D, Holmes P. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 57: 65-73, 1985.
32. Phillips C, Owens D, Collins P, Tomkin GH. Low density lipoprotein non-esterified fatty acids and lipoprotein lipase in diabetes. Atherosclerosis 181: 109-114, 2005.
33. Pitas RE, Innerarity TL, Weinstein JN, Mahley RW. Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Arteriosclerosis 1: 177-185, 1981.
34. Schwenke DC. Gender differences in intima-media permeability to low-density lipoprotein at atherosclerosis-prone aortic sites in rabbits. Lack of effect of 17β-estradiol. Arterioscler Thromb Vasc Biol 17: 2150-2157, 1997.
35. Suzuki T, Nakamura Y, Moriya T, Sasano H. Effects of steroid hormones on vascular functions. Microsc Res Tech 60: 76-84, 2003.
36. Symons JD, Mullick AE, Ensunsa JL, Ma AA, Rutledge JC. Hyperhomocysteinemia evoked by folate depletion: effects on coronary and carotid arterial function. Arterioscler Thromb Vasc Biol 22: 772-780, 2002.
37. Tooke JE. Microvascular function in human diabetes. A physiological perspective. Diabetes 44: 721-726, 1995.
38. Tse J, Martin-McNaulty B, Halks-Miller M, Kauser K, DelVecchio V, Vergona R, Sullivan ME, Rubanyi GM. Accelerated atherosclerosis and premature calcified cartilaginous metaplasia in the aorta of diabetic male Apo E knockout mice can be prevented by chronic treatment with 17β-estradiol. Atherosclerosis 144: 303-313, 1999.
39. Turgeon JL, McDonnell DP, Martin KA, Wise PM. Hormone therapy: physiological complexity belies therapeutic simplicity. Science 304: 1269-1273, 2004.
40. Villablanca A, Lubahn D, Shelby L, Lloyd K, Barthold S. Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor alpha. Arterioscler Thromb Vasc Biol 24: 1055-1061, 2004.
41. Wagner JD, Zhang L, Greaves KA, Shadoan MK, Schwenke DC. Soy protein reduces the arterial low-density lipoprotein (LDL) concentration and delivery of LDL cholesterol to the arteries of diabetic and nondiabetic male cynomolgus monkeys. Metabolism 49: 1188-1196, 2000.
42. Walsh BA, Busch BL, Mullick AE, Reiser KM, Rutledge JC. 17β-estradiol reduces glycoxidative damage in the artery wall. Arterioscler Thromb Vasc Biol 19: 840-846, 1999.
43. Walsh BA, Mullick AE, Banka CE, Rutledge JC. 17β-estradiol acts separately on the LDL particle and artery wall to reduce LDL accumulation. J Lipid Res 41: 134-141, 2000.
44. Walsh BA, Mullick AE, Walzem RL, Rutledge JC. 17β-estradiol reduces tumor necrosis factor-α-mediated LDL accumulation in the artery wall. J Lipid Res 40: 387-396, 1999.
45. Wiernsperger NF, Bouskela E.Microcirculation in insulin resistance and diabetes: more than just a complication. Diabetes Metab 29: 6S77-6S87, 2003.
46. Williamson JR, Ostrow E, Eades D, Chang K, Allison W, Kilo C, Sherman WR. Glucose-induced microvascular functional changes in nondiabetic rats are stereospecific and are prevented by an aldose reductase inhibitor. J Clin Invest 85: 1167-1172, 1990.
47. Ye L, Martin TA, Parr C, Harrison GM, Mansel RE, Jiang WG. Biphasic effects of 17β-estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells. J Cell Physiol 196: 362-369, 2003.